BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29310933)

  • 21. Cardiac implantable electronic device dysfunctions in patients undergoing radiotherapy: A prospective cohort study.
    Frey P; Irles D; Dompnier A; Akret C; Hosu IC; Narayanan K; Mazoyer F; Yayehd K; Guillon B; Marijon E
    J Cardiovasc Electrophysiol; 2022 May; 33(5):1013-1023. PubMed ID: 35299286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy.
    Brambatti M; Mathew R; Strang B; Dean J; Goyal A; Hayward JE; Long L; DeMeis P; Smoke M; Connolly SJ; Morillo CA; Amit G; Capucci A; Healey JS
    Heart Rhythm; 2015 Oct; 12(10):2148-54. PubMed ID: 26049049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of device malfunction in cancer patients with implantable cardiac device undergoing radiotherapy: a population-based cohort study.
    Zaremba T; Jakobsen AR; Søgaard M; Thøgersen AM; Johansen MB; Madsen LB; Riahi S
    Pacing Clin Electrophysiol; 2015 Mar; 38(3):343-56. PubMed ID: 25601489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients.
    Malavasi VL; Imberti JF; Tosetti A; Romiti GF; Vitolo M; Zecchin M; Mazzeo E; Giuseppina M; Lohr F; Lopez-Fernandez T; Boriani G
    Eur J Clin Invest; 2023 Jan; 53(1):e13862. PubMed ID: 36004486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy for patients with cardiovascular implantable electronic devices: an 11-year experience.
    Yeung C; Hazim B; Campbell D; Gooding J; Li SX; Tam HK; Hopman WM; Chacko S; Redfearn DP; Simpson C; Abdollah H; Baranchuk A
    J Interv Card Electrophysiol; 2019 Sep; 55(3):333-341. PubMed ID: 30603854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of patients with pacemakers or implantable cardioverter defibrillator undergoing radiotherapy].
    Huertas A; Thuillot M; Bibault JE; Sharifzadehgan A; Laurans M; Giraud P; Lavergne T; Marijon É; Durdux C
    Cancer Radiother; 2018 Oct; 22(6-7):515-521. PubMed ID: 30153976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors.
    Gomez DR; Poenisch F; Pinnix CC; Sheu T; Chang JY; Memon N; Mohan R; Rozner MA; Dougherty AH
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):570-5. PubMed ID: 24074931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiotherapy-induced malfunctions of cardiac implantable electronic devices: A meta-analysis.
    Xu B; Wang Y; Tse G; Chen J; Li G; Korantzopoulos P; Liu T
    Heart Rhythm; 2023 May; 20(5):689-698. PubMed ID: 36708909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of radiation therapy on permanent pacemaker and implantable cardioverter-defibrillator function.
    Makkar A; Prisciandaro J; Agarwal S; Lusk M; Horwood L; Moran J; Fox C; Hayman JA; Ghanbari H; Roberts B; Belardi D; Latchamsetty R; Crawford T; Good E; Jongnarangsin K; Bogun F; Chugh A; Oral H; Morady F; Pelosi F
    Heart Rhythm; 2012 Dec; 9(12):1964-8. PubMed ID: 23102626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of pacemaker or implantable cardioverter defibrillator after radiotherapy for early-stage breast cancer in Denmark, 1982-2005.
    Rehammar JC; Johansen JB; Jensen MB; Videbæk L; Jørgensen OD; Lorenzen E; Ewertz M
    Radiother Oncol; 2017 Jan; 122(1):60-65. PubMed ID: 27641785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of particle radiotherapy on the functioning of cardiac implantable electronic devices: a systematic review of in vitro and in vivo studies according to PICO criteria.
    Barcellini A; Dusi V; Mirandola A; Ronchi S; Riva G; Dal Mas F; Massaro M; Vitolo V; Ciocca M; Rordorf R; Orlandi E
    Radiol Med; 2022 Sep; 127(9):1046-1058. PubMed ID: 35871428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized in vitro evaluation of transient and permanent cardiac implantable electronic device malfunctions following direct exposure up to 10 Gy.
    Falco MD; Genovesi D; Caravatta L; Di Carlo C; Bliakharskaia E; Appignani M; Faustino M; Furia N; Di Girolamo E
    Strahlenther Onkol; 2021 Mar; 197(3):198-208. PubMed ID: 32561941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of patients with implanted cardiac devices during radiotherapy: results of a Spanish survey in radiation oncology departments.
    Sabater S; Montero A; López Fernández T; González Ferrer JJ; Arenas M
    Clin Transl Oncol; 2018 Dec; 20(12):1577-1581. PubMed ID: 29796996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electromagnetic interference on cardiac pacemakers and implantable cardioverter defibrillators during endoscopy as reported to the US Federal Drug Administration.
    Samuels JM; Overbey DM; Wikiel KJ; Jones TS; Robinson TN; Jones EL
    Surg Endosc; 2021 Jul; 35(7):3796-3801. PubMed ID: 32804270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of lung stereotactic ablative radiotherapy for the functioning of cardiac implantable electronic devices.
    Levis M; Andreis A; Badellino S; Budano C; Caivano D; Cerrato M; Orlandi E; Bissolino A; Angelico G; Cavallin C; Giglioli FR; De Ferrari GM; Ricardi U
    Radiother Oncol; 2021 Mar; 156():193-198. PubMed ID: 33387584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with cardiac implantable electronic devices undergoing radiotherapy in Poland. Expert opinion of the Heart Rhythm Section of the Polish Cardiac Society and the Polish Society of Radiation Oncology.
    Tajstra M; Blamek S; Niedziela JT; Gadula-Gacek E; Przybylski A; Blicharz J; Oręziak A; Miszczyk L; Gepner K; Fijuth J; Składowski K; Leszek P; Kempa M; Kowalski O; Sterliński M
    Kardiol Pol; 2019 Nov; 77(11):1106-1116. PubMed ID: 31741466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging in patients with cardiovascular implantable electronic devices: part 2-imaging after device implantation. A clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association (EHRA) of the ESC.
    Stankovic I; Voigt JU; Burri H; Muraru D; Sade LE; Haugaa KH; Lumens J; Biffi M; Dacher JN; Marsan NA; Bakelants E; Manisty C; Dweck MR; Smiseth OA; Donal E; ;
    Eur Heart J Cardiovasc Imaging; 2023 Dec; 25(1):e33-e54. PubMed ID: 37861420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician.
    Atreya AR; Cook JR; Lindenauer PK
    Postgrad Med; 2016; 128(2):223-30. PubMed ID: 26849147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexistence of deep brain stimulators and cardiac implantable electronic devices: A systematic review of safety.
    Akhoundi FH; Contarino MF; Fasano A; Vaidyanathan J; Ziaee M; Tabatabaee SN; Rohani M
    Parkinsonism Relat Disord; 2021 Jul; 88():129-135. PubMed ID: 34011446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy is safe in patients with implantable cardiac devices. Analysis of a systematic interrogation follow-up.
    López-Honrubia V; Hidalgo-Olivares VM; Dobón-Roux M; Martí-Laosa MM; Castro-Larefors S; Fernandez-Lopez J; Andres I; Roche O; Rovirosa A; Arenas M; Martinez-Terol F; López Fernández T; Sabater S
    Clin Transl Oncol; 2020 Dec; 22(12):2286-2292. PubMed ID: 32419111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.